Icahn Enterprises L.P.
NASDAQ:IEPConglomerates
+$0.03 today
- Market cap
- $2.13B
- Beta
- 0.75
- P/E (TTM)
- -13.0
- EPS (TTM)
- -$0.56
- Dividend yield
- 27.34%
Volume 4.99M
Average 0.95M
IEP Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Icahn Enterprises L.P.NASDAQ: IEP
Research & Development · Q2 FY2026 · quarter ended Jun 2026
Research & development remains negative
Q2 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How IEP compares with its peers on the latest reported figures
- IEP's LTM Jun 2026 research & development of $0 is the highest of the 8 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for IEP, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | -47.7% | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | -100.0% | — | 0.0% | |
| Peer median (excluding IEP) | $0 | -100.0% | -47.7% | 0.0% | |
Competitors are the stored peer set for IEP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 12.29B | 14.42B | 11.92B | 10.17B | 9.41B |
| Cost of Revenue | 9.96B | 12.22B | 9.98B | 9.24B | 8.58B |
| Gross Profit | 2.33B | 2.2B | 1.95B | 935M | 834M |
| Gross Margin | 19.0% | 15.3% | 16.3% | 9.2% | 8.9% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 1.24B | 1.25B | 852M | 783M | 837M |
| Operating Expenses | 1.24B | 1.25B | 852M | 783M | 837M |
| Depreciation & Amortization | 517M | 509M | 518M | 511M | 603M |
| EBITDA | 605M | 1.09B | 150M | 467M | 762M |
| EBITDA Margin | 4.9% | 7.5% | 1.3% | 4.6% | 8.1% |
| Operating Income | 1.09B | 950M | 1.1B | 152M | (3M) |
| Operating Margin | 8.9% | 6.6% | 9.2% | 1.5% | -0.0% |
| Interest Income | 137M | 328M | 636M | 477M | 0 |
| Interest Expense | 666M | 568M | 554M | 523M | 504M |
| Other Income / Expenses | (1.67B) | (941M) | (2.02B) | (719M) | (342M) |
| Income Before Tax | (578M) | 9M | (922M) | (567M) | (345M) |
| Pre-Tax Margin | -4.7% | 0.1% | -7.7% | -5.6% | -3.7% |
| Income Tax Expense | (78M) | 34M | 90M | (25M) | (19M) |
| Net Income | (604M) | (179M) | (670M) | (436M) | (293M) |
| Net Margin | -4.9% | -1.2% | -5.6% | -4.3% | -3.1% |
| EPS (Basic) | (2.32) | (0.57) | (1.75) | (0.94) | (0.52) |
| EPS (Diluted) | (2.32) | (0.57) | (1.75) | (0.94) | (0.52) |
| Weighted Avg Shares | 260M | 316M | 382M | 466M | 575M |
| Weighted Avg Shares (Diluted) | 260M | 316M | 382M | 466M | 575M |
Icahn Enterprises L.P.
NASDAQ:IEP
Intrinsic Alpha fair value
Locked
Current Price
$2.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.